Cognitive impairment and employment status in systemic lupus erythematosus: A prospective longitudinal study

Arthritis Care and Research

Volumn 61, Issue 5, 2009, Pages 680-687

  Appenzeller, Simone ^a   Cendes, Fernando ^a   Costallat, Lilian T L ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADULT; AMNESIA; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; COGNITIVE DEFECT; COMPREHENSION; CORTICOSTEROID THERAPY; DEPRESSION; DISEASE ASSOCIATION; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROPSYCHOLOGICAL TEST; PROBLEM SOLVING; PROSPECTIVE STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS; UNEMPLOYMENT;

ADOLESCENT; ADULT; ANTIBODIES, ANTICARDIOLIPIN; ATTENTION; COGNITION DISORDERS; DEPRESSION; EMPLOYMENT; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEMORY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 66249133954     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.24346     Document Type: Article

References (61)

1. West SG. Neuropsychiatric lupus. Rheum Dis Clin North Am 1994;20:129-58.
2. Hanly JG, Walsh NM, Sangalang V. Brain pathology in systemic lupus erythematosus. J Rheumatol 1992;19:732-41.
3. Johnson RT, Richardson EP. The neurological manifestations of systemic lupus erythematosus. Medicine (Baltimore) 1968; 47:337-69.
4. Hanly JG. Neuropsychiatric lupus. Rheum Dis Clin North Am 2005;31:273-98.
5. Hanly JG, McCurdy G, Fougere L, Douglas JA, Thompson K. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol 2004;31: 2156-62.
6. Mikdashi J, Handwerger B. Predictors of neuropsychiatric 7. Robert M, Sunitha R, Thulaseedharan NK. Neuropsychiatric manifestations systemic lupus erythematosus: a study from South India. Neurol India 2006;54:75-7.
7. Jonsen A, Bengston AA, Nived O, Rayberg B, Sturfelt G. Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality. Rheumatology (Oxford) 2002;41:1308-12.
8. Yelin E, Cisternas MG, Pasta DJ, Trupin L, Murphy L, Helmick 10. Panopalis P, Julian L, Yazdany J, Zell Gillis J, Trupin L, Hersh A, et al. Impact of memory impairment on employment status in persons with systemic lupus erythematosus. Arthritis Rheum 2007;57:1453-60.
9. Fowler W, Abresch R, Koch T, Brewer M, Bowden R, Wanlass R. Employment profiles in neuromuscular diseases. Am J Phys Med Rehabil 1997;76:26-37.
10. Ip RY, Dornan J, Schentag C. Traumatic brain injury: factors predicting return to work or school. Brain Inj 1995;9:517-32.
11. Heaton R, Chelune G, Lehman R. Using neuropsychological and personality tests to assess the likelihood of patient employment. J Nerv Ment Dis 1978;166:408-16.
12. Godfrey H, Bishara S, Partridge F, Knight R. Neuropsychological impairment and return to work following severe closed head injury: implications for clinical management. N Z Med J 1993;106:301-3.
13. Schwab K, Grafman J, Salazar A, Kraft J. Residual impairment and work status 15 years after penetrating head injury: report from the Viet Nam Head Injury Study. Neurology 1993;43: 95-103.
14. Rabkin JG, McElhiney M, Ferrando SJ, Van Gorp W, Lin SH. 17. Poole JL, Atanasoff G, Pelsor JC, Sibbitt WL Jr, Brooks WM. Relationships between person and health factors and job characteristics in women with systemic lupus erythematosus. Work 2007;28:95-100.
15. Yelin E, Trupin L, Katz P, Criswell L, Yazdany J, Gillis J, et al. Work dynamics among persons with systemic lupus erythematosus. Arthritis Rheum 2007;57:56-63.
16. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25: 1271-7.
17. Harris EN, Gharavi AE, Patel SP, Hughes GR. Evaluation of the anticardiolipine antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987;68:215- 22.
18. Brandt JT, Triplett DA, Alving B, Scharrer I, on behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardization Committee of the ISTH. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995;74:1185-90.
19. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomencalture. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
20. Folstein MF, Folstein SE, Folstein PR. Mini mental state: a practical method for grading the cognitive state of patient for the clinician. J Psychiatr Res 1975;12:189-98.
21. Wechsler D. The measurement of adult intelligence. Baltimore (MD): Williams & Wilkins; 1939.
22. Ryan JJ, Schnakenberg-Ott SD. Scoring reliability on the Wechsler Adult Intelligence Scale Third Edition (WAIS-III). Assessment 2003;10:151-9.
23. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test Research Edition manual. San Antonio: The Psychological Corporation; 1987.
24. Lezak MD. Neuropsychological assessment. New York: Oxford University Press; 1995.
25. Heaton RK, Chelune GJ, Talley JL, Kay GG, Curtiss G. Wisconsin Card Sorting Test Manual, revised and expanded. Odessa: Psychological Assessment Resources; 1993.
26. Beck AT, Beamesderfer A. Assessment of depression: the depression inventory. Mod Probl Pharmacopsychiat 1974;7: 151-69.
27. Beck AT, Rial WY, Rickels K. Short form of depression inventory: cross-validation. Psychol Rep 1974;34:1184-6.
28. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale: a review of validation data and clinical results. J Psychosom Res 1997;42:17-41.
29. Overall JE, Beller SA. The Brief Psychiatric Rating Scale (BPRS) in geropsychiatric research. I. Factor structure on an inpatient unit. J Gerontol 1984;39:187-93.
30. Gladman DD, Urowitz MB, Kagal A, Hallett D. Accurately describing changes in disease activity in systemic lupus erythematosus. J Rheumatol 2000;27:377-9.
31. Ibanez D, Urowitz MB, Gladman DD. Summarizing disease features over time. I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus. J Rheumatol 2003;30:1977-82.
32. Gladman DD, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, Gordon C, et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:809-13.
33. Stein H, Walters K, Dillon A, Schulzer M. Systemic lupus 37. Sturfelt G, Nived O. Clinical inconsistency, benign course and normal employment rates in unselected systemic lupus erythematosus. Clin Exp Rheumatol 1985;3:303-10.
34. Utset TO, Fink J, Doninger NA. Prevalence of neurocognitive dysfunction and other clinical manifestations in disabled patients with systemic lupus erythematosus. J Rheumatol 2006; 33:531-8.
35. Boomsma MM, Bijl M, Stegeman CA, Kallenberg CG, Hoffman GS, Tervaert JW. Patients' perceptions of the effects of systemic lupus erythematosus on health, function, income, and interpersonal relationships: a comparison with Wegener's granulomatosis. Arthritis Rheum 2002;47:196-201.
36. Bertoli AM, Fernandez M, Alarcon GS, Vila LM, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XLI. Factors predictive of self-reported work disability. Ann Rheum Dis 2007;66:12-7.
37. Clarke AE, Penrod J, St Pierre Y, Petri MA, Manzi S, Isenberg DA, et al, and the Tri-Nation Study Group. Underestimating the value of women: assessing the indirect costs of women with systemic lupus erythematosus. J Rheumatol 2000;27: 2597-604.
38. Mau W, Listing J, Huscher D, Zeidler H, Zink A. Employment across chronic inflammatory rheumatic diseases and comparison with the general population. J Rheumatol 2005;32:721-8.
39. Partridge AJ, Karlson EW, Daltroy LH, Lew RA, Wright EA, Fossel AH, et al. Risk factors for early work disability in systemic lupus erythematosus: results from a multicenter study. Arthritis Rheum 1997;40:2199-206.
40. Sutcliffe N, Clarke AE, Gordon C, Farewell V, Isenberg DA. The association of socioeconomic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus. Rheumatology (Oxford) 1999;38:1130-7.
41. Bultink IE, Turkstra F, Dijkmans BA, Voskuyl AE. High prevalence of unemployment in patients with systemic lupus erythematosus: association with organ damage and healthrelatedquality of life. J Rheumatol 2008;35:1053-7.
42. Carbotte RM, Denburg SD, Denburg JA. Prevalence of cognitive impairment in systemic lupus erythematosus. J NervMental Dis 1986;174:357-64.
43. Wekking EM, Vingerhoets AJ, van Dam AP, Nossent JC, Swaak AJ. Cognitive and emotional disturbances in systemic lupus erythematosus. Psychother Psychosom 1991;55:126-31.
44. Ginsburg KS, Wright EA, Larson MG, Fossel AH, Albert M, Schur PH, et al. A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus. Arthritis Rheum 1992;35: 776-82.
45. Hanly JG, Fisk JD, Sherwood G, Jones E, Jones JV, Eastwood B. Cognitive impairment in patients with systemic lupus erythematosus. J Rheumatol 1992;19:562-7.
46. Hanly JG, Liang MH. Cognitive disorders in systemic lupus erythematosus: epidemiologic and clinical issues. Ann N Y Acad Sci 1997;823:60-8.
47. Kozora E, Thompson LL, West SG, Kotzin BL. Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 1996;39:2035-45.
48. Hanly JG, Harrison MJ. Management of neuropsychiatric lupus. Best Pract Res Clin Rheumatol 2005;19:799-821.
49. Carlomagno S, Migliaresi S, Ambrosone L, Sannino M, Sanges G, Di Iorio G. Cognitive impairment in systemic lupus erythematosus: a followup study. J Neurol 2000;247:273-9.
50. Karassa FB, Ioannidis JP, Boki KA, Touloumi G, Argyropoulou MI, Strigaris KA, et al. Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med 2000; 109:628-34.
51. Appenzeller S, Carnevalle AD, Li LM, Costallat LT, Cendes F. Hippocampal atrophy in systemic lupus erythematosus. Ann Rheum Dis 2006;65:1585-9.
52. Hanly JG, Fisk JD, Sherwood G, Eastwood B. Clinical course of cognitive dysfunction in systemic lupus erythematosus. J Rheumatol 1994;2:1825-31.
53. Hay EM, Huddy A, Black D, Mbaya P, Tomenson B, Bernstein RM. A prospective study of psychiatric disorder and cognitive function in systemic lupus erythematosus. Ann Rheum Dis 1994;53:298-303.
54. Waterloo K, Omdal R, Husby G, Mellgren SI. Neuropsycho- logical function in systemic lupus erythematosus: a five-year longitudinal study. Rheumatology (Oxford) 2002;41:411-5.
55. Denburg SD, Carbotte RM, Denburg JA. Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus. Arthritis Rheum 1994;37:1311-20.
56. Harrison MJ, Morris KA, Horton R, Toglia J, Barsky J, Chait S, et al. Results of intervention for lupus patients with selfperceived cognitive difficulties. Neurology 2005;65:1325-7.
57. Tomietto P, Annese V, D'agostini S, Venturini P, La Torre G, De Vita S, et al. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus. Arthritis Rheum 2007;57:1461-72.
58. Mortel KF, Meyer JS, Herod B, Thornby J. Education and occupation as risk factors for dementias of the Alzheimer and ischemic vascular types. Dementia 1995;6:55-62.
59. Denburg SD, Denburg JA. Cognitive dysfunction and antiphospholipidantibodies in systemic lupus erythematosus. Lupus 2003;12:883-90.
60. Hanly JG, Hong C, Smith S, Fisk JD. A prospective analysis of cognitive function and anticardiolipin antibodies in systemiclupus erythematosus. Arthritis Rheum 1999;42:728- 34.
61. Leritz E, Brandt J, Minor M, Reis-Jensen F, Petri M. Neuropsychological functioning and its relationship to antiphospholipid antibodies in patients with systemic lupus erythematosus. J Clin Exp Neuropsychol 2002;24:527-33.